Planet Lean: The Official online magazine of the Lean Global Network
A CEO shows us the Obeya room in his hospital

A CEO shows us the Obeya room in his hospital

Carlos Frederico Pinto
November 15, 2017

VIDEO - The CEO of a cancer center in Brazil gives us a tour of the their obeya room, taking us through their strategy deployment and explaining how it supports their mission of reducing the burden of cancer.


Gemba guide: Carlos Frederico Pinto, CEO, Instituto de Oncologia do Vale - São José dos Campos, Brazil


Our obeya is something of a "living room" - it constantly evolves as the problems we face change. It is from the "Green Room" that we monitor our performance, track metrics, devise our strategy and then deploy it across the business.

Check out the video below, in which I show you the visual management boards we use and explain how the room works.


THE GEMBA GUIDE

Carlos Frederico Pinto photograph
Carlos Frederico Pinto is the CEO of Instituto de Oncologia do Vale, in Brazil

Read more

Interview with Helen Zak on lean healthcare challenges
November 6, 2015
Interview with Helen Zak on lean healthcare challenges

INTERVIEW – At the recent European Lean Healthcare Transformation Summit, we sat down with Helen Zak for a few minutes to discuss the state of change in the healthcare sector.

Continue reading
Down the right track
April 16, 2019
Down the right track

NOTES FROM THE GEMBA – The author goes back to a train maintenance center she visited two years ago and finds an organization striving to learn continuously.

Continue reading
What is a real lean transformation?
June 24, 2021
What is a real lean transformation?

FEATURE – Looking at successful journeys, the authors explain why a true lean transformation requires a chain of mentoring in TPS to fulfil the promise of each person’s individual learning.

Continue reading
Lean and the global Covid-19 vaccine race
November 5, 2020
Lean and the global Covid-19 vaccine race

CASE STUDY – Pall Corporation used lean product and process development principles to create the process to produce billions of doses of the Oxford/AstraZeneca vaccine for Covid-19 in record time.

Continue reading

Read more

No items found.